---
title: "Skinvisible delays annual report for year ended December 31, 2024"
url: "https://aibio.space/news/skinvisible-delays-annual-report-year-ended-december-31-2024/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2025-03-31"
section: "Distress"
tickers: "OTC:SKVI"
source: "https://www.sec.gov/Archives/edgar/data/1085277/000166357725000088/skvi_nt10k.htm"
summary: "The company said it could not compile all the information for its financial statements in time. It expects to file within the fifteen-day grace period."
---

By the aibio.space news desk.

Sources

- [Skinvisible, Inc. NT 10-K (2025-03-31)](https://www.sec.gov/Archives/edgar/data/1085277/000166357725000088/skvi_nt10k.htm)

[SKVI](https://aibio.space/companies/skinvisible/)

2025-03-31

# Skinvisible delays annual report for year ended December 31, 2024

Tickers [SKVI](https://aibio.space/companies/skinvisible/)

The company said it could not compile all the information for its financial statements in time. It expects to file within the fifteen-day grace period.

## Key facts

- **Company**: Skinvisible, Inc. (OTC: SKVI)

- **News type**: Distress

- **Primary source**: [Skinvisible, Inc. NT 10-K (2025-03-31)](https://www.sec.gov/Archives/edgar/data/1085277/000166357725000088/skvi_nt10k.htm)

*The facade of a neoclassical court building at dusk. Photo: Carol M Highsmith, CC0, via rawpixel. The picture shows the field, not the companies named.*

Skinvisible, Inc. told the Securities and Exchange Commission that it could not file its Annual Report on Form 10-K for the year ended December 31, 2024 on time.

The company made the disclosure on Form 12b-25, a notice of late filing. A company files this form when it cannot meet a report deadline. For an annual report, it gives the company until the fifteenth calendar day after the original due date.

Skinvisible said it has been unable, without unreasonable effort or expense, "to timely compile all information for the financial statements and related disclosures required to be included in its Annual Report on Form 10-K for the year ended December 31, 2024."

The company said it expects to file the annual report on or before the end of the fifteen-day grace period provided by Rule 12b-25.

Skinvisible said it has filed all other periodic reports required during the preceding 12 months. It also said it does not expect a significant change in results of operations from the corresponding period of the last fiscal year to be reflected in the report.

The notice is dated March 31, 2025.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

SKVI

Skinvisible, Inc.

OTC · United States

Open the starter desk

## More in Distress

Distress

### [Mineralys takes ownership of lorundrostat patents but keeps Tanabe milestone debts](https://aibio.space/news/mineralys-takes-ownership-lorundrostat-patents-but-keeps-tanabe/)

Oct 29, 2026

Distress

### [Bristol Myers Squibb drops Prothena's PRX019, ending up to $617.5 million in milestones](https://aibio.space/news/bristol-myers-squibb-drops-prothenas-prx019-ending-up-617-5-million/)

Oct 29, 2026

Distress

### [LENZ Therapeutics reorganizes to cut 2027 operating expenses by more than 50%](https://aibio.space/news/lenz-therapeutics-reorganizes-cut-2027-operating-expenses-more-50/)

Oct 28, 2026

---
Source page: https://aibio.space/news/skinvisible-delays-annual-report-year-ended-december-31-2024/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Skinvisible delays annual report for year ended December 31, 2024", 2025-03-31, https://aibio.space/news/skinvisible-delays-annual-report-year-ended-december-31-2024/